Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 379, Issue 4, pp 413–415 | Cite as

Should we be cautious on the use of commercially available antibodies to dopamine receptors?

  • Serena Bodei
  • Nicola Arrighi
  • PierFranco Spano
  • Sandra Sigala
Short Communication

Abstract

Evidence indicate that it is difficult to obtain specific antibodies to G protein-coupled receptors and different technical difficulties may allow the generation of antibodies that lack specificity. We conducted experiments to validate the specificity of commercially available antibodies raised against dopamine (DA) receptors hD1, hD4, and hD5 using a transfection approach: we studied whether, in HEK 293 cells selectively transfected with the various cloned subtypes, each antibody generates bands only in cells expressing its cognate receptor but not in those expressing the other DA receptors. Our results demonstrated that hD1 and hD4 receptor antibodies recognize not only their respective epitope, but also other DA receptor subtypes, while for the hD5 receptor detection, we observed a signal only in the lane loaded with hD5-transfected HEK 293 cells, although with a lack of purity. Therefore, we recommend caution on the use of commercially available DA receptor antibodies.

Keywords

Dopamine receptors Selectivity Western blot 

References

  1. Arrighi N, Bodei S, Zani D, Simeone C, Fiorentini C, Missale C, Milanese G, Dellabella M, Muzzonigro G, Cosciani Cunico S, Spano PF, Sigala S (2008) Molecular and pharmacological detection of dopaminergic receptors in the human male urinary tract. Neurourol Urodyn (in press) doi:10.1002/nau.20652
  2. Fiorentini C, Gardoni F, Spano P, Di Luca M, Missale C (2003) Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-d-aspartate receptors. J Biol Chem 278:20196–20202PubMedCrossRefGoogle Scholar
  3. Gupta A, Devi LA (2006) The use of receptor-specific antibodies to study G-protein-coupled receptors. Mt Sinai J Med 73:673–681PubMedGoogle Scholar
  4. Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277:93–96PubMedCrossRefGoogle Scholar
  5. Mackrill JJ (2004) Generation, use, and validation of receptor-selective antibodies. Methods Mol Biol 259:47–65PubMedGoogle Scholar
  6. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG (1998) Dopamine receptors: from structure to function. Physiol Rev 78:189–225PubMedGoogle Scholar
  7. Rhodes KJ, Trimmer JS (2006) Antibodies as valuable neuroscience research tools versus reagents of mass distraction. J Neurosci 26:8017–8020PubMedCrossRefGoogle Scholar
  8. Spano PF, Govoni S, Trabucchi M (1978) Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system. Adv Biochem Psychopharmacol 19:155–159PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Serena Bodei
    • 1
  • Nicola Arrighi
    • 1
    • 2
  • PierFranco Spano
    • 1
  • Sandra Sigala
    • 1
  1. 1.Section of Pharmacology, Department of Biomedical Sciences and BiotechnologiesUniversity of Brescia Medical SchoolBresciaItaly
  2. 2.Division of UrologyUniversity of Brescia Medical SchoolBresciaItaly

Personalised recommendations